申请人:Showell Graham Andrew
公开号:US20090209522A1
公开(公告)日:2009-08-20
A compound of formula (I): wherein either B is absent and A and Z are the same or different and are each hydrogen, halogen, alkyl, hydroxy, alkoxy, —CN, —C(R
c
)
2
OH, —N(R
d
)C(═X)R
c
, —C(═X)N(R
c
)(R
d
), —S(O)
m
—R
c
, —N(R
c
)(R
d
)S(O)
2
, —S(O)
2
N(R
c
)(R
d
), —N(R
c
)
2
, aryl optionally substituted with R
a
or —O-aryl optionally substituted with R
a
; or B is present and is —(CH
2
)
n
—, —C(R
b
)
2
— or —O—, or B taken together with A or Z can be —C═C(R
b
)—, —C(R
b
)═C—, —CH
2
—CH(R
b
)— or —CH(R
b
)—CH
2
—; D is —O— or —S(O)
m′
—; E is a bond or is —(CH
2
)
n
—, —N(R
d
)—, —(CH
2
)
n
N(R
d
)— or —N(R
d
)(CH
2
)
n
—; F is —C(═X)—; G is —(CH
2
)
n
—, —N(R
d
)—, —(CH
2
)
n
N(R
d
)— or —N(R
d
)(CH
2
)
n
; J is a bond, —O—, —N(R
C
)C(═X)—, —C(═X)N(R
c
)—, —S(O)
m′
—, —N(R
c
)S(O)
m
—, —S(O)
n
N(R
c
)—, —N(R
c
)— or —N(R
g
)(R
h
); K is a bond, alkylene, cycloalkylene, cycloalkenylene, arylene, heterocycloalkylene, heterocycloalkylene or heteroarylene; and L is hydrogen or a terminal group; has therapeutic utility.
化合物的化学式(I):其中B可能不存在,而A和Z相同或不同,分别为氢、卤素、烷基、羟基、烷氧基、—CN、—C(Rc)2OH、—N(Rd)C(═X)Rc、—C(═X)N(Rc)(Rd)、—S(O)m—Rc、—N(Rc)(Rd)S(O)2、—S(O)2N(Rc)(Rd)、—N(Rc)2、取代为Ra的芳基或—O-取代为Ra的芳基;或B存在且为—(CH2)n—、—C(Rb)2—或—O—,或B与A或Z一起可以是—C═C(Rb)—、—C(Rb)═C—、—CH2—CH(Rb)—或—CH(Rb)—CH2—;D为—O—或—S(O)m′—;E为键或—(CH2)n—、—N(Rd)—、—(CH2)nN(Rd)—或—N(Rd)(CH2)n—;F为—C(═X)—;G为—(CH2)n—、—N(Rd)—、—(CH2)nN(Rd)—或—N(Rd)(CH2)n;J为键、—O—、—N(RC)C(═X)—、—C(═X)N(Rc)—、—S(O)m′—、—N(Rc)S(O)m—、—S(O)nN(Rc)—、—N(Rc)—或—N(Rg)(Rh);K为键、烷基、环烷基、环烯基、芳基、杂环烷基、杂环烷基或杂芳基;L为氢或端基;具有治疗效用。